The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: tikosyn     Quarter: 2016Q3

Total Drug/Injury Combinations: 207     Number of Pages: 11

DRUGNAME PT EventCount
TIKOSYN Pyrexia 1 view events
TIKOSYN Rash 1 view events
TIKOSYN Respiratory failure 1 view events
TIKOSYN Road traffic accident 1 view events
TIKOSYN Seizure 1 view events
TIKOSYN Sensation of foreign body 1 view events
TIKOSYN Skin abrasion 1 view events
TIKOSYN Somnolence 1 view events
TIKOSYN Suicidal ideation 1 view events
TIKOSYN Tachycardia 1 view events
TIKOSYN Throat irritation 1 view events
TIKOSYN Tinnitus 1 view events
TIKOSYN Torsade de pointes 1 view events
TIKOSYN Upper respiratory tract infection 1 view events
TIKOSYN Urinary tract disorder 1 view events
TIKOSYN Urinary tract infection bacterial 1 view events
TIKOSYN White blood cell count decreased 1 view events
TIKOSYN - DOFETILIDE (GENERIC) MAYNE PHARMACEUTICAL Abdominal discomfort 1 view events
TIKOSYN - DOFETILIDE (GENERIC) MAYNE PHARMACEUTICAL Decreased appetite 1 view events
TIKOSYN - DOFETILIDE (GENERIC) MAYNE PHARMACEUTICAL Diarrhoea 1 view events

Total Drug/Injury Combinations: 207     Number of Pages: 11

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)